| Methods matter: standard production platforms for recombinant AAV produce chemically and functionally distinct vectors NG Rumachik, SA Malaker, N Poweleit, LH Maynard, CM Adams, RD Leib, ... Molecular therapy Methods & clinical development 18, 98-118, 2020 | 108 | 2020 |
| Genome editing in large animal models LH Maynard, O Humbert, CW Peterson, HP Kiem Molecular Therapy 29 (11), 3140-3152, 2021 | 21 | 2021 |
| Fast-Seq: a simple method for rapid and inexpensive validation of packaged single-stranded adeno-associated viral genomes in academic settings LH Maynard, O Smith, NP Tilmans, E Tham, S Hosseinzadeh, W Tan, ... Human gene therapy methods 30 (6), 195-205, 2019 | 17 | 2019 |
| Targeted In Vivo Genome Modification AP May, E Tham, L Maynard, M Mignardi, NK Paulk, RT Leenay, ... US Patent App. 17/422,173, 2022 | | 2022 |
| Fast-Seq, a universal method for rapid and inexpensive genomic validation of rAAV vectors in preclinical settings L Maynard, N Tilmans, E Tham, S Hosseinzadeh, R Leenay, W Tan, ... | | 2019 |
